Unlock stock picks and a broker-level newsfeed that powers Wall Street.
2.2300
-0.0100
(-0.45%)
At close: April 1 at 4:00:00 PM EDT
2.2300
0.00
(0.00%)
Pre-Market: 8:12:31 AM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
122
109
370
1,500
--
Operating Expense
12,675
15,195
18,101
12,979
16,826
Operating Income
-12,558
-15,086
-17,731
-11,479
-16,826
Net Non Operating Interest Income Expense
175
405
454
8
15
Other Income Expense
--
12
20
25
-13
Pretax Income
-12,383
-14,669
-17,257
-11,446
-16,824
Tax Provision
2
2
2
2
2
Net Income Common Stockholders
-12,385
-14,671
-17,259
-11,448
-16,826
Diluted NI Available to Com Stockholders
-12,385
-14,671
-17,259
-11,448
-16,826
Basic EPS
-10.08
-19.20
-23.76
-15.84
-29.28
Diluted EPS
-10.08
-19.20
-23.76
-15.84
-29.28
Basic Average Shares
1,265.9640
762.0760
726.0850
725.2990
575.1660
Diluted Average Shares
1,265.9640
762.0760
726.0850
725.2990
575.1660
Total Operating Income as Reported
-12,558
-15,086
-17,731
-11,479
-16,826
Total Expenses
12,680
15,195
18,101
12,979
16,826
Net Income from Continuing & Discontinued Operation
-12,385
-14,671
-17,259
-11,448
-16,826
Normalized Income
-12,385
-14,683
-17,279
-11,448
-16,807
Interest Income
180
405
454
8
15
Net Interest Income
175
405
454
8
15
EBIT
-12,795
-15,086
-17,731
-11,479
-16,826
EBITDA
-12,519
-14,806
-17,438
-11,337
-16,785
Reconciled Depreciation
276
280
293
142
41
Net Income from Continuing Operation Net Minority Interest
-12,385
-14,671
-17,259
-11,448
-16,826
Total Unusual Items Excluding Goodwill
--
12
20
--
-19
Total Unusual Items
--
12
20
--
-19
Normalized EBITDA
-12,519
-14,818
-17,458
-11,337
-16,766
Tax Rate for Calcs
0.0002
--
--
0.0002
--
3/31/2021 - 2/14/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENVB Enveric Biosciences, Inc.
1.3100
-5.76%
IBO Impact BioMedical Inc.
0.8200
-5.75%
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
VRPX Virpax Pharmaceuticals, Inc.
1.2800
+6.67%
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%
WINT Windtree Therapeutics, Inc.
1.2000
-4.76%
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
GRI GRI Bio, Inc.
2.0200
-36.88%
CERO CERo Therapeutics Holdings, Inc.
0.7200
-1.37%